6533b834fe1ef96bd129cd89

RESEARCH PRODUCT

Ocular Penetration of Topically Applied Norfloxacin 0.3% in the Rabbits and in Humans

Guy A. GuyonnetAndré PechinotA. KazmierczakAlain M. BronCatherine P. Creuzot Garcher

subject

AdultMalemedicine.medical_specialtyConjunctivaAdolescentgenetic structures[SDV]Life Sciences [q-bio]EyeCorneaPharmacokineticsCorneaOphthalmologymedicineAnimalsHumansTissue DistributionPharmacology (medical)Chromatography High Pressure LiquidNorfloxacinAgedAntibacterial agentCorneal epitheliumAged 80 and overPharmacologyLagomorphabiologybusiness.industryPenetration (firestop)Middle Agedbiology.organism_classificationeye diseasesSurgeryOphthalmologymedicine.anatomical_structureFemaleRabbitssense organsOphthalmic SolutionsbusinessKeratoplasty PenetratingNorfloxacinmedicine.drug

description

The kinetics of topically applied norfloxacin 0.3 percent were studied in rabbit and man. All measurements were performed by high-pressure liquid chromatography. Norfloxacin concentrations were investigated five to 120 minutes in rabbit ocular tissues after instillation of a single drop. In normal eyes, after 30 minutes, mean +/- SEM levels were 14.3 +/- 3.7 micrograms/g in cornea, 3.3 +/- 0.7 micrograms/g in conjunctiva, 0.2 +/- 0.1 microgram/g in aqueous humor. After removal of the corneal epithelium concentrations were as follows: 84.2 +/- 15.8 micrograms/g, 7.3 +/- 2.3 micrograms/g, 8.6 +/- 1.9 micrograms/g respectively. Penetration in posterior ocular tissues were rather poor. In human eyes, the intracorneal concentrations were assessed in patients being operated on corneal grafts. After instillation of 5 drops, the concentration in cornea was 15.5 +/- 2.1 micrograms/g. These data show that therapeutic levels of norfloxacin can be achieved in anterior ocular tissues, which may be of help in superficial infections of the eye.

https://doi.org/10.1089/jop.1992.8.241